首页> 外文期刊>International Journal of Molecular Sciences >Lineage Decision-Making within Normal Haematopoietic and Leukemic Stem Cells
【24h】

Lineage Decision-Making within Normal Haematopoietic and Leukemic Stem Cells

机译:正常血液血肿和白血病干细胞内的谱系决策

获取原文
           

摘要

To produce the wide range of blood and immune cell types, haematopoietic stem cells can “choose” directly from the entire spectrum of blood cell fate-options. Affiliation to a single cell lineage can occur at the level of the haematopoietic stem cell and these cells are therefore a mixture of some pluripotent cells and many cells with lineage signatures. Even so, haematopoietic stem cells and their progeny that have chosen a particular fate can still “change their mind” and adopt a different developmental pathway. Many of the leukaemias arise in haematopoietic stem cells with the bulk of the often partially differentiated leukaemia cells belonging to just one cell type. We argue that the reason for this is that an oncogenic insult to the genome “hard wires” leukaemia stem cells, either through development or at some stage, to one cell lineage. Unlike normal haematopoietic stem cells, oncogene-transformed leukaemia stem cells and their progeny are unable to adopt an alternative pathway.
机译:为了产生各种血液和免疫细胞类型,血吞噬干细胞可以直接从整个血细胞命运选项中“选择”。对单个细胞谱系的隶属度可以在血包血干细胞的水平下发生,因此这些细胞是一些多能细胞的混合物和具有谱系象征的许多细胞。即便如此,血质病干细胞及其后代所选择的特定命运仍然可以“改变主意”并采用不同的发育途径。许多白血病在血型生干细胞中出现,其中大部分通常部分分化的白血病细胞属于一种细胞类型。我们认为这是一个致癌物质“硬线”白血病干细胞的原因,通过开发或在某个阶段到一种细胞谱系。与正常的血吞噬干细胞不同,癌基因转化的白血病干细胞及其后代不能采用替代途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号